Vitiligo: concise evidence based guidelines on diagnosis and management
- 1 August 2010
- journal article
- review article
- Published by Oxford University Press (OUP) in Postgraduate Medical Journal
- Vol. 86 (1018) , 466-471
Abstract
Vitiligo is a common disease that causes a great degree of psychological distress. In its classical forms it is easily recognised and diagnosed. This review provides an evidence based outline of the management of vitiligo, particularly with the non-specialist in mind. Treatments for vitiligo are generally unsatisfactory. The initial approach to a patient who is thought to have vitiligo is to make a definite diagnosis, offer psychological support, and suggest supportive treatments such as the use of camouflage cosmetics and sunscreens, or in some cases after discussion the option of no treatment. Active therapies open to the non-specialist, after an explanation of potential side effects, include the topical use of potent or highly potent steroids or calcineurin inhibitors for a defined period of time (usually 2 months), following which an assessment is made to establish whether or not there has been a response. Patients whose condition is difficult to diagnose, unresponsive to straightforward treatments, or is causing psychological distress, are usually referred to a dermatologist. Specialist dermatology units have at their disposal phototherapy, either narrow band ultraviolet B or in some cases photochemotherapy, which is the most effective treatment presently available and can be considered for symmetrical types of vitiligo. Depigmenting treatments and possibly surgical approaches may be appropriate for vitiligo in selected cases. There is no evidence that presently available systemic treatments are helpful and safe in vitiligo. There is a need for further research into the causes of vitiligo, and into discovering better treatments.Keywords
This publication has 27 references indexed in Scilit:
- Genome-Wide Association Study of Generalized Vitiligo in an Isolated European Founder Population Identifies SMOC2, in Close Proximity to IDDM8Journal of Investigative Dermatology, 2010
- Autoantigens in Vitiligo Identified by the Serological Selection of a Phage-Displayed Melanocyte cDNA Expression LibraryJournal of Investigative Dermatology, 2010
- A randomized, double-blinded, placebo-controlled trial of pseudocatalase cream and narrowband ultraviolet B in the treatment of vitiligoBritish Journal of Dermatology, 2009
- Vitiligo presentation in adults.Clinical and Experimental Dermatology, 2005
- What patients with vitiligo believe about their conditionInternational Journal of Dermatology, 2004
- Measuring Adjustment to Chronic Skin Disorders: Validation of a Self-Report Measure.Psychological Assessment, 2003
- Living with vitiligo: Dealing with differenceBritish Journal of Health Psychology, 2002
- Psychological factors in cutaneous disease: An overview of researchPsychology, Health & Medicine, 1999
- Monobenzylether of hydroquinone.British Journal of Dermatology, 1977
- A double-blind trial of 0.05% clobetasol proprionate in the treatment of vitiligoBritish Journal of Dermatology, 1977